The kidney health benefits of SGLT2 inhibitors extend to patient subgroups with chronic kidney disease (CKD) in combo with other conditions.

MADRID — Nearly half of people with type 2 diabetes (T2D) currently recommended to receive sodium-glucose cotransporter 2 (SGLT2) inhibitors for kidney protection would not actually benefit from ...

SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...

The researchers found that during a median follow-up of 4.4 years, the primary outcome event of presumed clinical onset of dementia occurred in 69 and 43 participants in the SGLT2 and dulaglutide ...

Over the last several quarters, we are seeing a clear trend in the S&P 500’s FCF yield. At the sector level, there is no ...

Fintel reports that on September 16, 2024, Morgan Stanley upgraded their outlook for Chart Industries (NYSE:GTLS) from ...

bDepartment of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein ...

THE LATEST findings from the FLOW trial, the first dedicated kidney outcomes trial with semaglutide in patients with Type 2 diabetes (T2D) and chronic kidney disease (CKD), were presented at the ...

The Rolling Stones claim a hit song in the U.K. again this week, as "Sweet Sounds of Heaven," their collaboration with Lady Gaga, returns to one chart. (EDITORIAL USE ONLY) (Photo by Kevin Mazur ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...